Dr. Péter Ferdinandy, MD, PhD, MBA


Date and place of birth:
1966, Békéscsaba

Email: sci.vicerector@semmelweis-univ.hu



Current positions

2018 – ongoing Vice-Rector for Science and Innovations, Semmelweis University
2011 -ongoing

Professor & Director, Department of Pharmacology and Pharmacotherapy, Medical Faculty – Semmelweis University, Budapest, Hungary.

2005 – 2019 Professor of Biochemistry (part-time), Head of the Cardiovascular Research Group – University of Szeged, Hungary
2003 – ongoing Founder and CEO of Pharmahungary Group,  Szeged, Hungary (spin-off companies)

Education and Scientific degrees

2004 DSc in medical sciences, Hungarian Academy of Sciences
2000-2004 MBA (Masters of Business Administration, Finance and Quality management), Budapest Technical University, Hungary
1999 Designation as registered Clinical-Pharmacologist
1997-1999 Postdoctoral training, Dept Pharmacology, University of Alberta, Edmonton, Canada
1995 December

PhD in biochemistry (score: excellent, “summa cum laude”)

1991-1995 PhD training, Departments of Physiology and Biochemistry, University of Szeged, Hungary
1991 September MD diploma (score: excellent, “summa cum laude”)
1985-1991 University of Szeged, Hungary

Teaching experience:

2004- Lecturer in Pharmacology, Semmelweis University, Budapest
1993- Lecturer in Biochemistry, University of Szeged, Hungary
1998-1999 Lecturer in Pharmacology, University of Alberta, Edmonton, Canada
1991-1994 Lecturer in Physiology, University of Szeged, Hungary

Scholarships, fellowships

1989-1991                 Scholarship of Hungarian Republic

1997-1999:                 Postdoc Fellow, MRC Canada, University of Alberta, Canada

2001-2005                  Szechenyi professorship, Hungarian Academy of Sciences

2013-2014                  Szentagothai professorship, National Excellence Program

Major awards

First prize, Young Investigator Award 1999, International Society for Heart Research

Major leadership positions at international scientific organizations

International Society for Heart Research, European Section
Working Group Cell Biology of the Heart, European Cardiology Society
President(2019-2023) Hungarian Society of Experimental and Clinical Pharmacology

Editorial board memberships

  • Editor-in-Chief: British Journal of Pharmacology, from Jan 1, 2023
  • Br J Pharmacol (Reviews Editor, Guest Editor, impakt factor 4.9)
  • J Mol Cell Cardiol (Editor, impakt factor 5.1)
  • Basic Res Cardiol (Editor, impakt factor 5.9)
  • J Pharmacol Tox Methods (Editor, impakt factor 2.2)
  • Vascular Pharmacology (Editor, impakt factor 3.7)


  • Native language: Hungarian
  • English (fluent)
  • German (basic understanding)

Scientometric data

  • Number of papers in international peer-reviewed journals: over 340 (source: PubMed)
  • Cumulative impact factor of full papers: over 1600
  • Total number of citations: over 23000, Hirsch index: 75 (source: Google Scholar)
  • Patent families: 6, software developments: 3 on the market
  • Listed on HIGHLYCITED researchers in 2014; 2017, 2020, 2021, 2022, 2023 (list of the most influential “highly cited” scientists)